Free COVID vaccines get narrower from 1 October — who misses out

What just happened

From 1 October 2026, COVID-19 vaccine funding in Australia changes fundamentally. The National COVID Vaccine Program — which has funded free COVID vaccination for all Australians since 2021 — ends. COVID vaccines transition onto the National Immunisation Program, which means free access narrows to defined high-risk groups.

Who gets a free vaccine from October:

• Adults aged 75 and over — one dose every six months
• Adults aged 65–74 — one dose annually
• Aboriginal and Torres Strait Islander people aged 50–74 — one dose annually
• Adults aged 18 and over with severe immunocompromise — one dose annually

Everyone outside those categories will pay for vaccination. How much they pay, and where they access it, will depend on state and territory arrangements still being finalised.

This is six weeks away.

Both-and

Why the transition to NIP makes sense from a policy perspective

The shift mirrors what happened to influenza vaccines years ago: a period of pandemic-era universal coverage followed by a narrowing of publicly funded access to those at highest risk of severe disease. That logic is defensible. The burden of severe COVID — hospitalisation, ICU admission, death — is heavily concentrated in people aged 65 and over and those with significant immunocompromise. Focusing publicly funded doses on those groups reflects where the clinical benefit is greatest on a population basis.

The epidemiological context has changed too. Australia has recorded approximately 62,000 COVID cases in 2026 to date, compared to 185,000 in 2025 and over 10 million at the 2022 pandemic peak. COVID circulates endemically — it causes significant illness, but at population levels that differ fundamentally from the acute pandemic phase in which universal vaccination was the appropriate response.

What experts are warning about

The risks clinicians are flagging are not primarily about the policy rationale — they are about communication and implementation.

Professor Paul Griffin, an infectious diseases specialist, has specifically warned that GPs need to handle the transition messaging carefully: making sure patients do not interpret a change in how a vaccine is funded as a signal that the vaccine, or the disease, is less important. That conflation is predictable and potentially harmful. If people outside the high-risk categories disengage from COVID vaccination because they read the NIP transition as “the government says it’s not a big deal now,” population-level immunity deteriorates — including for people in the vulnerable groups who benefit partly from reduced community transmission.

Dr Rodney Pearce has flagged a second concern: state-by-state NIP administration creates inconsistency. Different ordering systems, different distribution channels, different patient-facing messaging across states. That complexity is genuinely difficult for general practice to navigate — particularly near state borders — and risks creating uneven access and inconsistent advice.

The position of healthcare workers and aged care staff also needs clarifying. Under the current National COVID Vaccine Program, workers in high-risk settings have had supported access to vaccination. The NIP arrangements may not automatically carry that coverage. If occupational vaccination rates fall in aged care or hospital settings, the people who depend on those settings bear the downstream risk.

What the Department of Health has said

Updated resources will be provided before 1 October, including revised vaccination recommendations, state-specific ordering guidance, and patient-facing materials. The Department has indicated these will arrive in time for the changeover. Whether they arrive early enough for GPs to prepare their patient populations is a different question.

My two cents

Six weeks is not much runway for a programme change of this scale. If you are working in general practice, now is the time to check what your state’s post-October arrangements will be for ordering and administering COVID vaccines — not in late September when the resources arrive.

For patients: if you are outside the high-risk categories but have vaccinated regularly and want to continue doing so, the conversation to have with your GP is about your individual risk profile, not only what the programme covers. Underlying conditions that do not meet the threshold for “severe immunocompromise” — type 2 diabetes, chronic lung disease, obesity, cardiac disease — are not in the free category, but they are factors that meaningfully shape individual COVID risk. Whether it is worth paying for vaccination given those factors is a legitimate personal health decision, not a purely financial one.

What is not worth doing is letting the programme change quietly reshape your thinking about COVID’s significance. The shift to NIP is a funding and logistics decision. It does not mean the virus has stopped mattering.

Verdict: yes — if you or someone you care for might lose free access on 1 October, speak with your GP about the new arrangements before then.

---

Sources cited

1. COVID-19 vaccines to move onto NIP. newsGP, RACGP, 19 August 2026. https://www1.racgp.org.au/newsgp/professional/covid-19-vaccines-to-move-onto-nip